COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 1996: Articles 19951-19960  | Next

A network modelling approach to assess non-pharmaceutical disease controls in a worker population: An application to SARS-CoV-2
Hill, E. M., Atkins, B. D., Keeling, M. J., Dyson, L., Tildesley, M. J.
10.1101/2020.11.18.20230649 — Posted: 2020-11-20
Multicenter evaluation of the Panbio COVID-19 Rapid Antigen-Detection Test for the diagnosis of SARS-CoV-2 infection
Merino-Amador, P., Guinea, J., Munoz-Gallego, I., Gonzalez-Donapetry, P., Galan, J. C., Antona, N., Cilla, G., Hernaez-Crespo, S., Diaz-de Tuesta, J.-L., Gual-de Torrella, A., Gonzalez-Romo, F., Escribano, P., Sanchez-Castellano, M. A., Sota-Busselo, M., Delgado-Iribarren, A., Garcia, J., Canton, R., Munoz, P., Folgueira, D., Cuenca-Estrella, M., Oteo-Iglesias, J., Spanish Panbio COVID-19 validation group
10.1101/2020.11.18.20230375 — Posted: 2020-11-20
The potential impact of School Closure Relative to Community-based Non-pharmaceutical Interventions on COVID-19 Cases in Ontario, Canada
Naimark, D. M., Mishra, S., Barrett, K., Khan, Y., Mac, S., Ximenes, R., Sander, B.
10.1101/2020.11.18.20234351 — Posted: 2020-11-20
Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: A Report of 2 Cases
Mendes-Correa, M. C., Leal, F. E., Villas-Boas, L. S., Witkin, S. S., de Paula, A., Tozetto-Mendoza, T. R., Ferreira, N. E., Curty, G., de Carvalho, P. S., Buss, L. F., Costa, S. F., Carvalho, F. M. d. C., Kawakami, J., Taniwaki, N. N., Paiao, H., Bizario, J. C. d. S., de Jesus, J. G., Sabino, E. C., Romano, C. M., Grepan, R. M. Z., Sesso, A.
10.1101/2020.11.18.20232546 — Posted: 2020-11-20
Effectiveness of remdesivir with and without dexamethasone in hospitalized patients with COVID-19
Garibaldi, B. T., Wang, K., Robinson, M. L., Zeger, S. L., Bandeen Roche, K., Wang, M.-C., Alexander, G. C., Gupta, A., Bollinger, R., Xu, Y.
10.1101/2020.11.19.20234153 — Posted: 2020-11-20
Mortality rates in matched cohort, pseudo-randomised and randomised trials of convalescent plasma given to COVID-19 patients.
Ahmad, A., Salsabil, M., Oliver, T.
10.1101/2020.11.19.20234757 — Posted: 2020-11-20
COVID-19 optimal vaccination policies: a modeling study on efficacy, natural and vaccine-induced immunity responses
Acuna-Zegarra, M. A., Diaz-Infante, S., Baca-Carrasco, D., Olmos Liceaga, D.
10.1101/2020.11.19.20235176 — Posted: 2020-11-20
Risk of evolutionary escape from neutralizing antibodies targeting SARS-CoV-2 spike protein
Van Egeren, D., Novokhodko, A., Stoddard, M., Tran, U., Zetter, B., Rogers, M., Pentelute, B. L., Carlson, J. M., Hixon, M. S., Joseph-McCarthy, D., Chakravarty, A.
10.1101/2020.11.17.20233726 — Posted: 2020-11-20
CLINICAL APPLICATIONS OF MACHINE LEARNING ON COVID-19: THE USE OF A DECISION TREE ALGORITHM FOR THE ASSESSMENT OF PERCEIVED STRESS IN MEXICAN HEALTHCARE PROFESSIONALS.
Delgado-Gallegos, J. L., Aviles-Rodriguez, G., Padilla-Rivas, G. R., Cosio-Leon, M. d. l. A., Franco-Villareal, H., Zuniga-Violante, E., Romo-Cardenas, G. S., Islas-Cisneros, J. F.
10.1101/2020.11.18.20233288 — Posted: 2020-11-20
The detection and stability of the SARS-CoV-2 RNA biomarkers in wastewater influent in Helsinki, Finland
Hokajarvi, A.-M., Rytkonen, A., Tiwari, A., Kauppinen, A., Oikarinen, S., Lehto, K.-M., Kankaanpaa, A., Gunnar, T., Al-Hello, H., Blomqvist, S., Miettinen, I. T., Savolainen-Kopra, C., Pitkanen, T.
10.1101/2020.11.18.20234039 — Posted: 2020-11-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).